Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06577766 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06577766 · ClinicalTrials.gov record · last posted 2026-08-17

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

StatusActive, Not Recruiting
PhasePhase 1
Started2024-09-03
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The study is testing a new study medicine to treat people living with overweight or obesity. The aim of this study is to see if the medicine is safe, how it works in your body, and what your body does to the study medicine. Participants will either get the study medicine or placebo (a "dummy medicine" similar to the study medicine but without active ingredients) given as an injection under your skin. Which treatment the participants get is decided by chance. The study medicine is a potential new medicine which cannot be prescribed by doctors.

Protocol amendment history 3 changes detected by DataLookout

2026-08-18
Trial sites expanded: 1 → 4 locations
2026-08-18
Primary completion pushed: 2026-09-24 → 2027-10-11
2026-08-18
Completion pushed: 2026-09-24 → 2027-10-11
Trial Details
NCT Number NCT06577766
Lead Sponsor Novo Nordisk A/S
Conditions Obesity, Overweight
Enrollment 63 participants
Start Date 2024-09-03
Primary Completion 2027-10-11 (estimated)
Study Completion 2027-10-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-17